Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products
This collaboration can provide a variety of NGS detection solutions

Twist Bioscience, a provider of high quality synthetic DNA through a silicon platform company, today announced a partnership with China's leading Berry Gene, a supplier of high-throughput sequencing (NGS) in China, has reached a strategic cooperation and will add Twist's NGS targeted enrichment and library preparation tools to its products, aiming to promote the high-standard development of precision medical in vitro diagnostics in China.

This product combines Berry Gene's expertise in genomics and high-throughput sequencing (NGS), as well as Twist Bioscience's large-scale manufacturing capabilities, and can provide a variety of NGS detection solutions. The combined product aims to provide researchers with high-quality tools for better application in the screening of tumours and genetic diseases.

"We are very happy to cooperate with Berry Gene, which is one of the most popular and leading companies in the gene sequencing industry in China," said Dr Emily M. Leproust, CEO and co-founder of Twist Bioscience. "Berry has extensive experience in transforming genetic testing technology into clinical applications and has achieved remarkable results. In recent years, Berry Gene has been at the forefront of using NGS to detect diseases and is committed to making more Chinese people enjoy To the health benefits of gene sequencing technology. Twist is honoured to add our NGS solution to Berry Gene’s products."

The NGS products provided by Twist are unique in that they have unparalleled uniformity and have all been quality-verified (QC). The new product will provide Berry Gene with the highest-quality NGS product portfolio today, which will further promote the high-standard development of precision medical in vitro diagnostics in China.

Berry Gene and Twist Bioscience will work closely to develop a more innovative and cutting-edge NGS product portfolio to maintain a leading position in the diagnosis and screening of genetic diseases, and provide Berry Gene with more, better and timely Research and IVD solutions.

Every oligonucleotide of Twist has been verified by NGS to ensure the accuracy of each probe sequence and the presence of all probes in the delivered probe pool, which will further improve the accuracy of our products. We are very I am glad to add Twist NGS series products to our product line. "Dr Zhou Daixing, general manager of Berry Gene said.

Tags : #TwistBioscience #LatestNewsonTwistBioscience22ndFeb #BerryGene #LatestNewsonBerryGene22ndFeb #LatestPharmaNews22ndFeb #LatestPharmaCollaboration22ndFeb #LatestNewsonGeneticDiseases #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

CARE Hospitals to Offer Free Vascular Health Check on National Vascular DayAugust 05, 2026
Breastfeeding Myths That New Mothers Should Stop BelievingAugust 05, 2026
Why Modern Lifestyle Causes Chronic InflammationAugust 05, 2026
Endometriosis Awareness: Understanding the Silent Condition Affecting Millions of Indian WomenAugust 05, 2026
A Complete Guide to Pregnancy Health Tips for Indian Women: Nutrition, Wellness, and What Every Expectant Mother Should KnowAugust 05, 2026
Metropolis Healthcare reports strong Q1FY27 performance, with revenue up 17% to ₹450 crore and EBITDA up 27% YoYAugust 04, 2026
India's Silent Liver Health Crisis: New Data Points to Urgent Need for Screening and PreventionAugust 04, 2026
Eureka Forbes Launches 'Ghar Ka New Favourite' Campaign showcasing Forbes SmartClean Robotic Vacuum Cleaner with Shraddha KapoorAugust 04, 2026
Why Preventive Healthcare for Children Is One of the Most Important Investments India Can MakeAugust 04, 2026
The Role of Pathology in Healthcare: From Diagnosis to Disease PreventionAugust 04, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 04, 2026
Comprehensive Evaluation of Syncope: Cardiac vs. Neurological Origin WorkupsAugust 04, 2026
Common Medical Terms Explained: A Plain-Language Guide for Indian Patients and Healthcare SeekersAugust 03, 2026
Why Radiology Is the Backbone of Modern Medical Diagnosis and TreatmentAugust 03, 2026
Managing Urban Stress: Science-Backed Strategies for Mental Resilience in 2026 August 01, 2026
Managing Chronic Inflammation: The Role of Anti-Inflammatory Indian SuperfoodsAugust 01, 2026
Pathophysiology of Psoriatic Arthritis: Clinical Presentation, Joint Damage Mitigation, and BiologicsAugust 01, 2026
Early Markers of Glaucoma: Structural vs. Functional Ophthalmic Diagnostic ProtocolsAugust 01, 2026
Managing Complex Diabetic Foot Ulcers: Multidisciplinary Wound Care, Offloading, and RevascularizationAugust 01, 2026
The Future of Preventive Medicine: How India Is Moving From Cure to PreventionAugust 01, 2026